World's Best-Selling Med; Cost-Effectiveness of GLP-1 Drugs; TED Drug Heads to FDA

World's Best-Selling Med; Cost-Effectiveness of GLP-1 Drugs; TED Drug Heads to FDA

News and commentary from the endocrinology world

Challenging the Hype: Why GLP-1s Won't Replace Bariatric Procedures (and What Might) – RamaOnHealthcare

I like a good challenge.Few are tougher than parsing real-world evidence, expert opinions, and the ever-growing medical literature to reach a solid conclusion about a particular topic. It’s especially difficult when a novel medication or procedure bursts onto the scene, promising a major breakthrough.It’s even more difficult when that breakthrough has the potential to revolutionize [...]

Bariatric Surgery May Cut Costs and Weight More Than GLP-1 Drugs

Despite growing prescription numbers and spending on glucagon-like peptide 1 (GLP-1) receptor agonists for obesity treatment, metabolic bariatric surgery may result in greater weight loss and lower costs, according to a recent study in JAMA Surgery. This comes as obesity experts have noticed decreased demand for the weight-loss surgery, which is often considered the “last resort” in obesity treatment.